25 XP   0   0   10

Hanmi Science
Buy, Hold or Sell?

Let's analyse Hanmi Science together

PenkeI guess you are interested in Hanmi Science. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hanmi Science. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hanmi Science

I send you an email if I find something interesting about Hanmi Science.

Quick analysis of Hanmi Science (30 sec.)










What can you expect buying and holding a share of Hanmi Science? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
₩11,583.45
Expected worth in 1 year
₩12,463.77
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
₩880.33
Return On Investment
2.8%

For what price can you sell your share?

Current Price per Share
₩32,000.00
Expected price per share
₩29,650 - ₩35,900
How sure are you?
50%

1. Valuation of Hanmi Science (5 min.)




Live pricePrice per Share (EOD)

₩32,000.00

Intrinsic Value Per Share

₩-4,974.24 - ₩3,560.76

Total Value Per Share

₩6,609.21 - ₩15,144.21

2. Growth of Hanmi Science (5 min.)




Is Hanmi Science growing?

Current yearPrevious yearGrowGrow %
How rich?$551.2m$500.5m$38.7m7.2%

How much money is Hanmi Science making?

Current yearPrevious yearGrowGrow %
Making money$20.1m$12.1m$8m39.9%
Net Profit Margin9.2%6.6%--

How much money comes from the company's main activities?

3. Financial Health of Hanmi Science (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#18 / 40

Most Revenue
#25 / 40

Most Profit
#16 / 40

What can you expect buying and holding a share of Hanmi Science? (5 min.)

Welcome investor! Hanmi Science's management wants to use your money to grow the business. In return you get a share of Hanmi Science.

What can you expect buying and holding a share of Hanmi Science?

First you should know what it really means to hold a share of Hanmi Science. And how you can make/lose money.

Speculation

The Price per Share of Hanmi Science is ₩32,000. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hanmi Science.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hanmi Science, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩11,583.45. Based on the TTM, the Book Value Change Per Share is ₩220.08 per quarter. Based on the YOY, the Book Value Change Per Share is ₩127.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hanmi Science.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.360.0%0.300.0%0.180.0%0.140.0%0.140.0%
Usd Book Value Change Per Share0.000.0%0.150.0%0.090.0%0.070.0%0.100.0%
Usd Dividend Per Share0.000.0%0.000.0%0.070.0%0.070.0%0.070.0%
Usd Total Gains Per Share0.000.0%0.150.0%0.160.0%0.140.0%0.170.0%
Usd Price Per Share27.44-25.24-26.02-33.69-45.61-
Price to Earnings Ratio19.27-21.67-37.93-66.24-95.54-
Price-to-Total Gains Ratio10,237.66-2,652.88--25.46-609.59--915.81-
Price to Book Ratio3.38-3.19-3.53-4.77-7.20-
Price-to-Total Gains Ratio10,237.66-2,652.88--25.46-609.59--915.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share22.4
Number of shares44
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.07
Usd Book Value Change Per Share0.150.07
Usd Total Gains Per Share0.150.14
Gains per Quarter (44 shares)6.786.21
Gains per Year (44 shares)27.1124.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102717131215
205444262440
308171393665
4010898524890
501361256460115
601631527772140
701901799084165
8021720610396190
90244233116107215
100271260129119240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%36.03.01.090.0%43.03.02.089.6%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%28.012.00.070.0%34.014.00.070.8%
Dividend per Share0.00.04.00.0%6.00.06.050.0%12.00.08.060.0%20.00.020.050.0%20.00.028.041.7%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%31.09.00.077.5%37.011.00.077.1%

Fundamentals of Hanmi Science

About Hanmi Science

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-14 23:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Hanmi Science.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hanmi Science earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • A Net Profit Margin of 10.4% means that ₩0.10 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hanmi Science:

  • The MRQ is 10.4%. The company is making a huge profit. +2
  • The TTM is 9.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM9.2%+1.2%
TTM9.2%YOY6.6%+2.6%
TTM9.2%5Y5.4%+3.9%
5Y5.4%10Y5.9%-0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4%2.1%+8.3%
TTM9.2%2.1%+7.1%
YOY6.6%2.5%+4.1%
5Y5.4%2.2%+3.2%
10Y5.9%2.3%+3.6%
1.1.2. Return on Assets

Shows how efficient Hanmi Science is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • 2.8% Return on Assets means that Hanmi Science generated ₩0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hanmi Science:

  • The MRQ is 2.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.5%+0.3%
TTM2.5%YOY1.7%+0.8%
TTM2.5%5Y1.4%+1.1%
5Y1.4%10Y1.4%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%1.6%+1.2%
TTM2.5%1.7%+0.8%
YOY1.7%1.2%+0.5%
5Y1.4%1.1%+0.3%
10Y1.4%1.6%-0.2%
1.1.3. Return on Equity

Shows how efficient Hanmi Science is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • 4.4% Return on Equity means Hanmi Science generated ₩0.04 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hanmi Science:

  • The MRQ is 4.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM3.7%+0.7%
TTM3.7%YOY2.4%+1.3%
TTM3.7%5Y2.0%+1.8%
5Y2.0%10Y2.2%-0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%4.3%+0.1%
TTM3.7%3.7%+0.0%
YOY2.4%2.8%-0.4%
5Y2.0%3.5%-1.5%
10Y2.2%3.9%-1.7%

1.2. Operating Efficiency of Hanmi Science.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hanmi Science is operating .

  • Measures how much profit Hanmi Science makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hanmi Science:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.1%-2.1%
TTM-5Y2.8%-2.8%
5Y2.8%10Y1.6%+1.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-2.9%
TTM-2.9%-2.9%
YOY2.1%3.9%-1.8%
5Y2.8%3.5%-0.7%
10Y1.6%3.4%-1.8%
1.2.2. Operating Ratio

Measures how efficient Hanmi Science is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are ₩1.72 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Hanmi Science:

  • The MRQ is 1.723. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.347. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.723TTM1.347+0.376
TTM1.347YOY1.619-0.272
TTM1.3475Y1.694-0.347
5Y1.69410Y1.331+0.364
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7231.642+0.081
TTM1.3471.594-0.247
YOY1.6191.431+0.188
5Y1.6941.365+0.329
10Y1.3311.229+0.102

1.3. Liquidity of Hanmi Science.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hanmi Science is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 0.69 means the company has ₩0.69 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Hanmi Science:

  • The MRQ is 0.693. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.711. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.693TTM0.711-0.018
TTM0.711YOY0.941-0.230
TTM0.7115Y0.906-0.195
5Y0.90610Y0.699+0.207
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6931.389-0.696
TTM0.7111.400-0.689
YOY0.9411.424-0.483
5Y0.9061.411-0.505
10Y0.6991.329-0.630
1.3.2. Quick Ratio

Measures if Hanmi Science is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • A Quick Ratio of 0.29 means the company can pay off ₩0.29 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hanmi Science:

  • The MRQ is 0.288. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.300. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.300-0.012
TTM0.300YOY0.378-0.078
TTM0.3005Y0.372-0.072
5Y0.37210Y0.405-0.034
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2880.730-0.442
TTM0.3000.745-0.445
YOY0.3780.798-0.420
5Y0.3720.784-0.412
10Y0.4050.850-0.445

1.4. Solvency of Hanmi Science.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hanmi Science assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hanmi Science to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.36 means that Hanmi Science assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hanmi Science:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.332. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.332+0.026
TTM0.332YOY0.277+0.055
TTM0.3325Y0.294+0.038
5Y0.29410Y0.321-0.027
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3580.609-0.251
TTM0.3320.606-0.274
YOY0.2770.600-0.323
5Y0.2940.580-0.286
10Y0.3210.586-0.265
1.4.2. Debt to Equity Ratio

Measures if Hanmi Science is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hanmi Science to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 55.7% means that company has ₩0.56 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hanmi Science:

  • The MRQ is 0.557. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.498. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.557TTM0.498+0.059
TTM0.498YOY0.387+0.111
TTM0.4985Y0.419+0.078
5Y0.41910Y0.484-0.064
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5571.554-0.997
TTM0.4981.554-1.056
YOY0.3871.688-1.301
5Y0.4191.675-1.256
10Y0.4841.759-1.275

2. Market Valuation of Hanmi Science

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Hanmi Science generates.

  • Above 15 is considered overpriced but always compare Hanmi Science to the Medical Distribution industry mean.
  • A PE ratio of 19.27 means the investor is paying ₩19.27 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hanmi Science:

  • The EOD is 15.731. Based on the earnings, the company is fair priced.
  • The MRQ is 19.271. Based on the earnings, the company is fair priced.
  • The TTM is 21.672. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD15.731MRQ19.271-3.539
MRQ19.271TTM21.672-2.402
TTM21.672YOY37.929-16.256
TTM21.6725Y66.239-44.567
5Y66.23910Y95.540-29.300
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD15.73112.427+3.304
MRQ19.27114.424+4.847
TTM21.67215.740+5.932
YOY37.92918.752+19.177
5Y66.23915.472+50.767
10Y95.54019.379+76.161
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hanmi Science:

  • The EOD is -93.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -114.589. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 14.981. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-93.542MRQ-114.589+21.047
MRQ-114.589TTM14.981-129.570
TTM14.981YOY90.760-75.779
TTM14.9815Y225.142-210.161
5Y225.14210Y110.791+114.352
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-93.5427.168-100.710
MRQ-114.5896.758-121.347
TTM14.98112.327+2.654
YOY90.7603.478+87.282
5Y225.1423.969+221.173
10Y110.7913.188+107.603
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hanmi Science is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 3.38 means the investor is paying ₩3.38 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Hanmi Science:

  • The EOD is 2.763. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.384. Based on the equity, the company is fair priced.
  • The TTM is 3.186. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.763MRQ3.384-0.622
MRQ3.384TTM3.186+0.199
TTM3.186YOY3.531-0.346
TTM3.1865Y4.775-1.589
5Y4.77510Y7.200-2.425
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.7630.988+1.775
MRQ3.3841.157+2.227
TTM3.1861.157+2.029
YOY3.5311.208+2.323
5Y4.7751.257+3.518
10Y7.2001.922+5.278
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hanmi Science compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.829220.081-98%127.202-97%96.926-96%138.558-97%
Book Value Per Share--11583.44711332.135+2%10559.570+10%10220.045+13%9316.584+24%
Current Ratio--0.6930.711-3%0.941-26%0.906-24%0.699-1%
Debt To Asset Ratio--0.3580.332+8%0.277+29%0.294+22%0.321+11%
Debt To Equity Ratio--0.5570.498+12%0.387+44%0.419+33%0.484+15%
Dividend Per Share----0%97.401-100%104.696-100%99.018-100%
Eps--508.548423.349+20%255.523+99%206.871+146%200.897+153%
Free Cash Flow Per Share---85.52397.380-188%4.096-2188%45.697-287%167.298-151%
Free Cash Flow To Equity Per Share---85.52397.380-188%-18.880-78%33.004-359%221.003-139%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--3560.763--------
Intrinsic Value_10Y_min---4974.240--------
Intrinsic Value_1Y_max--624.842--------
Intrinsic Value_1Y_min--75.027--------
Intrinsic Value_3Y_max--1673.130--------
Intrinsic Value_3Y_min---269.945--------
Intrinsic Value_5Y_max--2475.162--------
Intrinsic Value_5Y_min---1155.176--------
Market Cap2166838272000.000-23%2664916548000.0002451621250312.500+9%2517256291610.254+6%3260490522820.046-18%4412937197402.364-40%
Net Profit Margin--0.1040.092+13%0.066+59%0.054+94%0.059+75%
Operating Margin----0%0.021-100%0.028-100%0.016-100%
Operating Ratio--1.7231.347+28%1.619+6%1.694+2%1.331+30%
Pb Ratio2.763-23%3.3843.186+6%3.531-4%4.775-29%7.200-53%
Pe Ratio15.731-23%19.27121.672-11%37.929-49%66.239-71%95.540-80%
Price Per Share32000.000-23%39200.00036062.500+9%37174.995+5%48122.485-19%65156.207-40%
Price To Free Cash Flow Ratio-93.542+18%-114.58914.981-865%90.760-226%225.142-151%110.791-203%
Price To Total Gains Ratio8357.276-23%10237.6632652.883+286%-25.457+100%609.587+1579%-915.814+109%
Quick Ratio--0.2880.300-4%0.378-24%0.372-23%0.405-29%
Return On Assets--0.0280.025+13%0.017+63%0.014+107%0.014+96%
Return On Equity--0.0440.037+18%0.024+82%0.020+125%0.022+101%
Total Gains Per Share--3.829220.081-98%224.602-98%201.622-98%237.576-98%
Usd Book Value--551230728.573539271315.550+2%500519280.413+10%484852487.275+14%441815508.381+25%
Usd Book Value Change Per Share--0.0030.154-98%0.089-97%0.068-96%0.097-97%
Usd Book Value Per Share--8.1087.932+2%7.392+10%7.154+13%6.522+24%
Usd Dividend Per Share----0%0.068-100%0.073-100%0.069-100%
Usd Eps--0.3560.296+20%0.179+99%0.145+146%0.141+153%
Usd Free Cash Flow---4069840.7054634122.680-188%194128.636-2196%2169674.573-288%7931672.799-151%
Usd Free Cash Flow Per Share---0.0600.068-188%0.003-2188%0.032-287%0.117-151%
Usd Free Cash Flow To Equity Per Share---0.0600.068-188%-0.013-78%0.023-359%0.155-139%
Usd Market Cap1516786790.400-23%1865441583.6001716134875.219+9%1762079404.127+6%2282343365.974-18%3089056038.182-40%
Usd Price Per Share22.400-23%27.44025.244+9%26.022+5%33.686-19%45.609-40%
Usd Profit--24200663.20020146264.735+20%12111676.173+100%9821554.162+146%9530396.678+154%
Usd Revenue--232350790.245218383616.336+6%183059486.978+27%172134467.748+35%144431823.464+61%
Usd Total Gains Per Share--0.0030.154-98%0.157-98%0.141-98%0.166-98%
 EOD+3 -5MRQTTM+16 -16YOY+17 -185Y+15 -2010Y+16 -20

3.2. Fundamental Score

Let's check the fundamental score of Hanmi Science based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.731
Price to Book Ratio (EOD)Between0-12.763
Net Profit Margin (MRQ)Greater than00.104
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.288
Current Ratio (MRQ)Greater than10.693
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.557
Return on Equity (MRQ)Greater than0.150.044
Return on Assets (MRQ)Greater than0.050.028
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Hanmi Science based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.728
Ma 20Greater thanMa 5037,272.500
Ma 50Greater thanMa 10039,651.000
Ma 100Greater thanMa 20039,282.500
OpenGreater thanClose32,400.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets1,226,170,046
Total Liabilities438,697,577
Total Stockholder Equity787,506,951
 As reported
Total Liabilities 438,697,577
Total Stockholder Equity+ 787,506,951
Total Assets = 1,226,170,046

Assets

Total Assets1,226,170,046
Total Current Assets273,900,397
Long-term Assets952,269,649
Total Current Assets
Cash And Cash Equivalents 27,578,959
Short-term Investments 6,928,896
Net Receivables 106,875,702
Inventory 104,868,808
Other Current Assets 20,399,855
Total Current Assets  (as reported)273,900,397
Total Current Assets  (calculated)266,652,220
+/- 7,248,177
Long-term Assets
Property Plant Equipment 94,068,246
Intangible Assets 67,138,044
Long-term Assets Other 0
Long-term Assets  (as reported)952,269,649
Long-term Assets  (calculated)161,206,291
+/- 791,063,359

Liabilities & Shareholders' Equity

Total Current Liabilities395,202,032
Long-term Liabilities43,495,545
Total Stockholder Equity787,506,951
Total Current Liabilities
Short Long Term Debt 202,161,111
Accounts payable 59,841,711
Other Current Liabilities -1
Total Current Liabilities  (as reported)395,202,032
Total Current Liabilities  (calculated)262,002,822
+/- 133,199,210
Long-term Liabilities
Long term Debt 10,197,480
Capital Lease Obligations Min Short Term Debt1,377,482
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)43,495,545
Long-term Liabilities  (calculated)11,574,962
+/- 31,920,583
Total Stockholder Equity
Retained Earnings 533,274,488
Total Stockholder Equity (as reported)787,506,951
Total Stockholder Equity (calculated)533,274,488
+/- 254,232,463
Other
Capital Stock34,978,470
Common Stock Shares Outstanding 67,983
Net Debt 184,779,633
Net Invested Capital 999,865,542
Net Working Capital -121,301,634
Property Plant and Equipment Gross 114,861,910



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
401,910,396
408,762,483
426,645,600
485,394,283
528,891,498
534,842,963
577,865,374
579,822,998
690,387,702
715,196,196
732,265,132
742,795,234
764,664,733
787,146,044
777,294,551
932,024,384
925,155,622
868,724,902
962,047,985
969,248,669
934,208,960
932,581,275
956,131,827
938,783,180
935,841,839
931,564,171
930,760,012
916,545,956
943,223,798
920,554,610
930,468,100
910,832,377
905,170,201
907,734,166
910,587,030
923,219,549
925,128,603
931,452,600
945,939,441
949,894,436
956,196,415
938,765,719
963,941,672
1,109,690,934
1,138,666,935
1,108,739,425
1,141,723,138
1,226,170,046
1,226,170,0461,141,723,1381,108,739,4251,138,666,9351,109,690,934963,941,672938,765,719956,196,415949,894,436945,939,441931,452,600925,128,603923,219,549910,587,030907,734,166905,170,201910,832,377930,468,100920,554,610943,223,798916,545,956930,760,012931,564,171935,841,839938,783,180956,131,827932,581,275934,208,960969,248,669962,047,985868,724,902925,155,622932,024,384777,294,551787,146,044764,664,733742,795,234732,265,132715,196,196690,387,702579,822,998577,865,374534,842,963528,891,498485,394,283426,645,600408,762,483401,910,396
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
329,993,311
293,552,315
280,361,295
288,605,136
261,257,661
261,607,622
251,177,140
248,630,503
244,457,071
238,007,457
215,169,851
219,353,734
217,079,375
212,531,946
211,270,234
216,179,716
215,727,155
212,141,340
211,746,585
214,784,331
222,559,163
220,000,816
192,157,624
198,634,740
245,348,144
253,953,913
216,091,593
230,904,073
273,900,397
273,900,397230,904,073216,091,593253,953,913245,348,144198,634,740192,157,624220,000,816222,559,163214,784,331211,746,585212,141,340215,727,155216,179,716211,270,234212,531,946217,079,375219,353,734215,169,851238,007,457244,457,071248,630,503251,177,140261,607,622261,257,661288,605,136280,361,295293,552,315329,993,3110000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
102,545,986
69,613,406
57,126,476
68,642,090
38,360,456
25,286,230
30,336,472
24,890,924
26,857,834
28,832,728
13,814,705
16,641,017
16,747,179
14,629,148
14,304,575
15,954,302
14,848,698
14,330,841
16,141,678
16,636,326
16,591,043
13,863,548
17,453,185
18,017,948
21,420,647
23,654,518
18,447,604
28,123,904
27,578,959
27,578,95928,123,90418,447,60423,654,51821,420,64718,017,94817,453,18513,863,54816,591,04316,636,32616,141,67814,330,84114,848,69815,954,30214,304,57514,629,14816,747,17916,641,01713,814,70528,832,72826,857,83424,890,92430,336,47225,286,23038,360,45668,642,09057,126,47669,613,406102,545,9860000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,316,928
0
0
0
0
0
0
363,977
315,493
474,446
476,823
177,733
198,550
38,550
38,550
38,550
52,750
52,750
52,750
92,750
954,250
545,186
956,265
6,928,896
6,928,896956,265545,186954,25092,75052,75052,75052,75038,55038,55038,550198,550177,733476,823474,446315,493363,9770000002,316,928000000000000000000000000
       Net Receivables 
5,105,261
4,295,174
4,452,069
34,516,144
53,185,083
57,957,965
63,408,766
65,243,319
104,504,461
106,901,061
113,918,498
125,572,421
126,098,330
116,696,783
146,594,940
240,118,686
143,767,398
121,054,488
120,035,235
127,315,954
114,235,401
106,651,145
113,985,725
107,468,541
105,192,727
97,883,834
101,992,692
101,417,103
92,291,909
86,265,117
88,174,678
91,091,821
90,177,487
85,880,687
89,730,281
87,902,949
89,493,194
86,392,043
86,886,917
94,216,048
101,549,276
70,533,150
74,741,533
98,819,135
97,560,620
96,407,288
98,862,233
106,875,702
106,875,70298,862,23396,407,28897,560,62098,819,13574,741,53370,533,150101,549,27694,216,04886,886,91786,392,04389,493,19487,902,94989,730,28185,880,68790,177,48791,091,82188,174,67886,265,11792,291,909101,417,103101,992,69297,883,834105,192,727107,468,541113,985,725106,651,145114,235,401127,315,954120,035,235121,054,488143,767,398240,118,686146,594,940116,696,783126,098,330125,572,421113,918,498106,901,061104,504,46165,243,31963,408,76657,957,96553,185,08334,516,1444,452,0694,295,1745,105,261
       Inventory 
43,802
45,167
46,633
18,809,737
27,295,958
34,880,546
52,918,305
70,645,375
86,754,775
103,487,404
103,591,922
114,958,162
110,684,759
105,772,182
97,641,380
92,576,292
90,547,056
101,693,165
98,000,150
95,666,891
106,430,781
109,090,366
103,595,689
107,708,562
109,210,667
109,382,106
108,247,122
102,818,772
102,864,941
101,701,354
101,267,430
100,883,167
100,872,871
102,494,603
101,524,165
110,186,057
105,283,881
106,208,307
108,315,378
105,971,173
97,697,744
97,478,942
99,190,390
112,229,229
110,940,966
85,234,133
88,796,554
104,868,808
104,868,80888,796,55485,234,133110,940,966112,229,22999,190,39097,478,94297,697,744105,971,173108,315,378106,208,307105,283,881110,186,057101,524,165102,494,603100,872,871100,883,167101,267,430101,701,354102,864,941102,818,772108,247,122109,382,106109,210,667107,708,562103,595,689109,090,366106,430,78195,666,89198,000,150101,693,16590,547,05692,576,29297,641,380105,772,182110,684,759114,958,162103,591,922103,487,40486,754,77570,645,37552,918,30534,880,54627,295,95818,809,73746,63345,16743,802
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
705,216,342
705,384,759
711,114,367
693,753,002
692,638,256
696,463,933
694,407,313
707,492,395
712,987,263
719,706,015
731,155,110
727,335,273
736,195,599
746,608,094
765,306,932
864,342,791
884,713,022
892,647,831
910,819,066
952,269,649
952,269,649910,819,066892,647,831884,713,022864,342,791765,306,932746,608,094736,195,599727,335,273731,155,110719,706,015712,987,263707,492,395694,407,313696,463,933692,638,256693,753,002711,114,367705,384,759705,216,3420000000000000000000000000000
       Property Plant Equipment 
12,418,137
12,352,294
15,227,887
15,329,600
19,375,934
19,321,267
19,378,014
19,405,522
19,368,891
19,358,240
23,538,197
23,503,104
24,613,307
24,383,135
24,400,842
24,822,866
27,964,509
28,126,953
28,059,112
27,749,747
27,201,702
27,851,017
27,244,211
27,053,808
26,804,196
26,411,428
26,019,959
25,717,837
25,638,677
26,088,697
27,013,913
26,341,226
25,684,714
24,831,511
26,052,008
25,640,862
25,062,975
24,991,870
26,360,137
26,044,452
25,910,216
27,327,002
31,238,123
88,919,154
89,135,963
89,705,431
94,659,344
94,068,246
94,068,24694,659,34489,705,43189,135,96388,919,15431,238,12327,327,00225,910,21626,044,45226,360,13724,991,87025,062,97525,640,86226,052,00824,831,51125,684,71426,341,22627,013,91326,088,69725,638,67725,717,83726,019,95926,411,42826,804,19627,053,80827,244,21127,851,01727,201,70227,749,74728,059,11228,126,95327,964,50924,822,86624,400,84224,383,13524,613,30723,503,10423,538,19719,358,24019,368,89119,405,52219,378,01419,321,26719,375,93415,329,60015,227,88712,352,29412,418,137
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
566,676,123
568,962,748
577,469,488
593,218,275
603,770,643
600,059,024
606,921,357
609,664,035
599,543,890
632,419,396
633,187,794
637,822,069
619,534,007
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000619,534,007637,822,069633,187,794632,419,396599,543,890609,664,035606,921,357600,059,024603,770,643593,218,275577,469,488568,962,748566,676,1230000000000000000000
       Intangible Assets 
1,221,867
1,366,548
1,549,956
2,720,920
2,663,412
2,643,014
3,499,598
3,755,581
3,956,564
4,508,032
5,002,263
5,175,842
5,736,964
5,887,175
6,905,185
7,188,626
8,147,477
8,565,835
8,430,176
8,472,764
8,692,847
12,965,009
12,852,372
12,548,192
12,168,517
11,857,169
11,313,618
11,180,968
10,885,959
11,016,026
10,496,422
10,411,276
10,414,131
9,833,358
9,250,692
8,814,564
8,388,019
8,103,848
7,777,411
7,582,825
7,171,703
6,979,947
7,512,653
19,126,766
18,659,965
18,216,365
17,956,121
67,138,044
67,138,04417,956,12118,216,36518,659,96519,126,7667,512,6536,979,9477,171,7037,582,8257,777,4118,103,8488,388,0198,814,5649,250,6929,833,35810,414,13110,411,27610,496,42211,016,02610,885,95911,180,96811,313,61811,857,16912,168,51712,548,19212,852,37212,965,0098,692,8478,472,7648,430,1768,565,8358,147,4777,188,6266,905,1855,887,1755,736,9645,175,8425,002,2634,508,0323,956,5643,755,5813,499,5982,643,0142,663,4122,720,9201,549,9561,366,5481,221,867
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,522,620
4,490,776
3,529,982
2,795,902
6,928,196
3,524,297
6,334,720
7,832,447
11,426,005
11,868,267
11,818,407
0
10,015,046
10,231,987
1,325,151
0
1
0
-1
0
0-10101,325,15110,231,98710,015,046011,818,40711,868,26711,426,0057,832,4476,334,7203,524,2976,928,1962,795,9023,529,9824,490,7765,522,6200000000000000000000000000000
> Total Liabilities 
33,193,798
38,588,807
41,882,329
91,501,440
119,441,397
128,849,306
156,455,185
170,757,239
262,597,737
286,934,922
296,376,539
325,083,425
338,614,057
329,805,674
332,351,215
347,774,739
349,185,475
277,628,398
290,996,629
321,684,820
283,769,409
270,729,519
275,767,622
273,630,939
285,064,657
271,887,938
266,360,358
263,452,031
293,969,230
267,181,575
270,798,102
265,145,245
266,410,912
259,129,867
266,216,510
264,485,903
265,652,478
258,199,804
256,148,014
259,599,612
260,301,496
228,698,336
234,541,770
384,942,964
393,834,667
346,705,951
354,510,974
438,697,577
438,697,577354,510,974346,705,951393,834,667384,942,964234,541,770228,698,336260,301,496259,599,612256,148,014258,199,804265,652,478264,485,903266,216,510259,129,867266,410,912265,145,245270,798,102267,181,575293,969,230263,452,031266,360,358271,887,938285,064,657273,630,939275,767,622270,729,519283,769,409321,684,820290,996,629277,628,398349,185,475347,774,739332,351,215329,805,674338,614,057325,083,425296,376,539286,934,922262,597,737170,757,239156,455,185128,849,306119,441,39791,501,44041,882,32938,588,80733,193,798
   > Total Current Liabilities 
26,818,202
31,914,344
22,183,500
69,747,355
94,680,824
104,888,195
133,061,260
158,236,647
248,668,241
278,181,735
285,684,085
316,345,376
322,286,027
310,050,585
314,783,732
337,109,188
337,117,941
266,156,399
276,575,201
304,714,505
251,938,989
238,844,261
247,150,162
244,589,840
256,978,801
243,069,449
235,311,192
227,222,089
243,650,593
216,464,262
219,832,252
228,188,315
228,330,502
240,332,711
247,695,095
220,113,063
225,443,573
216,239,919
214,352,997
220,995,450
220,674,516
186,696,209
192,181,009
347,726,499
354,610,879
307,586,884
314,548,551
395,202,032
395,202,032314,548,551307,586,884354,610,879347,726,499192,181,009186,696,209220,674,516220,995,450214,352,997216,239,919225,443,573220,113,063247,695,095240,332,711228,330,502228,188,315219,832,252216,464,262243,650,593227,222,089235,311,192243,069,449256,978,801244,589,840247,150,162238,844,261251,938,989304,714,505276,575,201266,156,399337,117,941337,109,188314,783,732310,050,585322,286,027316,345,376285,684,085278,181,735248,668,241158,236,647133,061,260104,888,19594,680,82469,747,35522,183,50031,914,34426,818,202
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,000,000
25,000,000
25,000,000
25,000,000
25,000,000
20,000,000
20,000,000
0
0
40,000,000
45,000,000
44,000,000
44,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000044,000,00044,000,00045,000,00040,000,0000020,000,00020,000,00025,000,00025,000,00025,000,00025,000,00025,000,0000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,000,000
25,000,000
25,000,000
25,000,000
25,000,000
20,000,000
20,000,000
0
0
40,000,000
45,000,000
44,000,000
44,000,000
44,000,000
49,000,000
54,000,000
45,000,000
50,000,000
59,010,000
57,500,000
55,000,000
55,000,000
63,200,000
61,640,000
193,856,667
188,136,667
186,276,667
182,176,667
202,161,111
202,161,111182,176,667186,276,667188,136,667193,856,66761,640,00063,200,00055,000,00055,000,00057,500,00059,010,00050,000,00045,000,00054,000,00049,000,00044,000,00044,000,00044,000,00045,000,00040,000,0000020,000,00020,000,00025,000,00025,000,00025,000,00025,000,00025,000,0000000000000000000000
       Accounts payable 
68,075
61,249
65,003
44,963,703
69,709,856
79,024,784
100,319,483
117,178,493
163,853,866
187,429,451
182,467,577
213,447,035
221,855,981
207,177,935
216,299,878
211,395,294
203,889,565
0
0
197,397,603
0
0
0
176,923,328
0
0
0
153,550,028
0
0
0
130,912,042
0
0
0
123,932,498
0
0
105,482,102
104,567,782
0
0
0
77,557,270
0
21,731,733
34,341,162
59,841,711
59,841,71134,341,16221,731,733077,557,270000104,567,782105,482,10200123,932,498000130,912,042000153,550,028000176,923,328000197,397,60300203,889,565211,395,294216,299,878207,177,935221,855,981213,447,035182,467,577187,429,451163,853,866117,178,493100,319,48379,024,78469,709,85644,963,70365,00361,24968,075
       Other Current Liabilities 
16,656,714
16,758,183
6,981,607
7,584,345
7,818,788
8,708,937
15,584,670
23,898,728
27,814,375
33,752,284
31,216,508
32,898,341
30,430,046
32,872,650
38,483,854
85,713,894
93,228,376
241,156,399
251,575,201
82,316,902
226,938,989
213,844,261
222,150,162
42,666,512
236,978,801
220,971,869
213,205,409
49,690,592
201,520,317
-1
0
47,820,485
180,922,814
187,701,776
192,134,795
45,274,787
171,458,943
152,900,655
45,158,594
53,703,962
161,030,809
118,744,046
123,809,602
1
0
0
-1
-1
-1-1001123,809,602118,744,046161,030,80953,703,96245,158,594152,900,655171,458,94345,274,787192,134,795187,701,776180,922,81447,820,4850-1201,520,31749,690,592213,205,409220,971,869236,978,80142,666,512222,150,162213,844,261226,938,98982,316,902251,575,201241,156,39993,228,37685,713,89438,483,85432,872,65030,430,04632,898,34131,216,50833,752,28427,814,37523,898,72815,584,6708,708,9377,818,7887,584,3456,981,60716,758,18316,656,714
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,318,638
50,717,313
50,965,850
36,956,930
38,080,410
18,797,156
18,521,415
44,372,840
40,208,905
41,959,885
41,795,016
38,604,162
39,626,980
42,002,127
42,360,761
37,216,466
39,223,788
39,119,068
39,962,424
43,495,545
43,495,54539,962,42439,119,06839,223,78837,216,46642,360,76142,002,12739,626,98038,604,16241,795,01641,959,88540,208,90544,372,84018,521,41518,797,15638,080,41036,956,93050,965,85050,717,31350,318,6380000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-25,000,000
-25,000,000
-25,000,000
-25,000,000
-25,000,000
-20,000,000
-20,000,000
0
0
-39,178,385
-44,313,967
-42,189,316
-42,577,645
1,136,898
720,355
1,893,547
1,429,270
1,106,957
803,744
1,880,646
1,494,360
1,092,231
645,949
1,918,494
2,326,861
1,870,039
1,286,199
2,374,769
1,377,482
1,377,4822,374,7691,286,1991,870,0392,326,8611,918,494645,9491,092,2311,494,3601,880,646803,7441,106,9571,429,2701,893,547720,3551,136,898-42,577,645-42,189,316-44,313,967-39,178,38500-20,000,000-20,000,000-25,000,000-25,000,000-25,000,000-25,000,000-25,000,0000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
-1
188,679
1
-1
0
0
-1
0
0
0
0
-1
-1
1
0
01-1-10000-100-11188,679-1000100000000000000000000000000000
> Total Stockholder Equity
368,747,762
370,205,976
384,797,193
392,693,925
408,288,814
404,878,373
420,381,653
407,881,988
424,933,379
424,640,152
432,356,303
416,055,373
425,998,734
456,896,332
444,517,366
583,680,589
574,954,625
589,340,044
669,296,848
645,286,624
648,019,713
659,175,629
677,206,513
665,154,164
650,777,480
659,676,654
664,399,966
653,093,476
649,252,949
653,371,268
659,668,812
645,685,729
638,762,116
648,605,161
644,372,803
658,735,546
659,478,705
673,256,624
689,795,994
690,298,133
695,898,179
710,068,450
729,400,045
724,746,193
744,829,552
762,031,655
787,211,423
787,506,951
787,506,951787,211,423762,031,655744,829,552724,746,193729,400,045710,068,450695,898,179690,298,133689,795,994673,256,624659,478,705658,735,546644,372,803648,605,161638,762,116645,685,729659,668,812653,371,268649,252,949653,093,476664,399,966659,676,654650,777,480665,154,164677,206,513659,175,629648,019,713645,286,624669,296,848589,340,044574,954,625583,680,589444,517,366456,896,332425,998,734416,055,373432,356,303424,640,152424,933,379407,881,988420,381,653404,878,373408,288,814392,693,925384,797,193370,205,976368,747,762
   Common Stock
24,831,698
24,831,698
24,831,698
24,831,698
26,024,796
26,024,796
26,024,796
26,024,796
27,277,490
27,277,490
27,277,490
27,277,490
28,592,762
28,592,762
28,592,762
28,592,762
29,145,155
29,145,154
29,145,154
29,145,155
31,139,937
31,139,937
31,139,937
31,139,937
31,749,634
31,749,634
31,749,634
31,749,634
32,371,430
32,371,430
32,371,430
32,371,430
33,005,575
33,005,575
33,005,575
33,005,575
33,652,306
33,652,306
33,652,306
33,652,306
34,311,842
34,311,842
34,311,842
0
0
0
0
0
0000034,311,84234,311,84234,311,84233,652,30633,652,30633,652,30633,652,30633,005,57533,005,57533,005,57533,005,57532,371,43032,371,43032,371,43032,371,43031,749,63431,749,63431,749,63431,749,63431,139,93731,139,93731,139,93731,139,93729,145,15529,145,15429,145,15429,145,15528,592,76228,592,76228,592,76228,592,76227,277,49027,277,49027,277,49027,277,49026,024,79626,024,79626,024,79626,024,79624,831,69824,831,69824,831,69824,831,698
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-15,334,338-15,334,337-15,334,338-14,336,194-14,336,193-14,336,194-14,336,194-13,501,685-13,501,686-20,380,081-20,380,081-18,609,411-18,609,411-18,609,412-18,609,412-18,577,269-18,577,269-18,577,269-18,577,269-18,546,772-18,546,772-18,546,772-18,546,772-18,528,891-18,528,891-17,675,230-16,686,948
   Other Stockholders Equity 00000-27,555,121-31,608,501-31,746,480-34,197,376-31,123,566-31,545,335-34,552,654-37,637,493-34,311,647-28,650,494-39,471,443-39,058,238-22,389,336-22,624,963-15,842,840-19,216,963-19,721,712-15,762,719-16,987,825-16,237,314-2,034,127-8,995,677-10,921,095-6,888,1010000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,247,906,379
Cost of Revenue-982,802,657
Gross Profit265,103,722265,103,722
 
Operating Income (+$)
Gross Profit265,103,722
Operating Expense-1,191,667,520
Operating Income57,011,916-926,563,798
 
Operating Expense (+$)
Research Development0
Selling General Administrative106,365,653
Selling And Marketing Expenses0
Operating Expense1,191,667,520106,365,653
 
Net Interest Income (+$)
Interest Income643,372
Interest Expense-10,160,601
Other Finance Cost-42,279
Net Interest Income-9,559,508
 
Pretax Income (+$)
Operating Income57,011,916
Net Interest Income-9,559,508
Other Non-Operating Income Expenses0
Income Before Tax (EBT)130,541,64757,011,916
EBIT - interestExpense = -10,160,601
115,121,513
125,282,114
Interest Expense10,160,601
Earnings Before Interest and Taxes (EBIT)0140,702,248
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax130,541,647
Tax Provision-15,421,789
Net Income From Continuing Ops115,119,858115,119,858
Net Income115,121,513
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net09,559,508
 

Technical Analysis of Hanmi Science
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hanmi Science. The general trend of Hanmi Science is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hanmi Science's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hanmi Science.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 34,100 < 34,100 < 35,900.

The bearish price targets are: 29,900 > 29,850 > 29,650.

Tweet this
Hanmi Science Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hanmi Science. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hanmi Science Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hanmi Science. The current macd is -2,172.84548168.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hanmi Science price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hanmi Science. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hanmi Science price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hanmi Science Daily Moving Average Convergence/Divergence (MACD) ChartHanmi Science Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hanmi Science. The current adx is 18.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hanmi Science shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hanmi Science Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hanmi Science. The current sar is 37,385.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hanmi Science Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hanmi Science. The current rsi is 33.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hanmi Science Daily Relative Strength Index (RSI) ChartHanmi Science Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hanmi Science. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hanmi Science price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Hanmi Science Daily Stochastic Oscillator ChartHanmi Science Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hanmi Science. The current cci is -121.23522684.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hanmi Science Daily Commodity Channel Index (CCI) ChartHanmi Science Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hanmi Science. The current cmo is -41.1134204.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hanmi Science Daily Chande Momentum Oscillator (CMO) ChartHanmi Science Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hanmi Science. The current willr is -91.75824176.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hanmi Science Daily Williams %R ChartHanmi Science Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hanmi Science.

Hanmi Science Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hanmi Science. The current atr is 2,003.

Hanmi Science Daily Average True Range (ATR) ChartHanmi Science Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hanmi Science. The current obv is 6,617,195.

Hanmi Science Daily On-Balance Volume (OBV) ChartHanmi Science Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hanmi Science. The current mfi is 42.96.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hanmi Science Daily Money Flow Index (MFI) ChartHanmi Science Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hanmi Science.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hanmi Science Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hanmi Science based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.728
Ma 20Greater thanMa 5037,272.500
Ma 50Greater thanMa 10039,651.000
Ma 100Greater thanMa 20039,282.500
OpenGreater thanClose32,400.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hanmi Science with someone you think should read this too:
  • Are you bullish or bearish on Hanmi Science? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hanmi Science? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hanmi Science

I send you an email if I find something interesting about Hanmi Science.


Comments

How you think about this?

Leave a comment

Stay informed about Hanmi Science.

Receive notifications about Hanmi Science in your mailbox!